Related Experiment Videos
Biopharmaceutical study of insulin suppositories
Die Pharmazie
|January 1, 1981
Summary
Insulin can be effectively delivered rectally using suppositories. Brij 58, an absorption-promoting surfactant, significantly enhanced insulin absorption in rabbit rectal models.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Biopharmaceutics
Background:
- Insulin therapy is crucial for diabetes management.
- Rectal administration offers an alternative route for drug delivery.
- Developing effective rectal insulin formulations is challenging.
Purpose of the Study:
- To investigate the feasibility of insulin administration via suppositories.
- To evaluate the impact of various carriers on rectal insulin absorption.
- To identify optimal surfactants for enhancing insulin bioavailability.
Main Methods:
- Insulin was formulated into suppository dosage forms with different carriers.
- Rectal absorption of insulin was studied in rabbit models.
- The efficacy of Brij 58 as an absorption-promoting surfactant was assessed.
Main Results:
- Significant insulin absorption was achieved through rectal administration.
- Suppositories containing Brij 58 demonstrated highly effective insulin absorption.
- Brij 58 acted as a potent absorption-promoting surfactant.
Conclusions:
- Insulin administration in suppository form is viable.
- Brij 58 significantly enhances rectal insulin absorption.
- Rectal insulin suppositories represent a promising alternative delivery method.